151 related articles for article (PubMed ID: 30971332)
21. Thalidomide in toxic epidermal necrolysis.
Levy R
Lancet; 1999 Jan; 353(9149):324. PubMed ID: 9929048
[No Abstract] [Full Text] [Related]
22. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.
Schneider JA; Cohen PR
Adv Ther; 2017 Jun; 34(6):1235-1244. PubMed ID: 28439852
[TBL] [Abstract][Full Text] [Related]
23. Comparison of effectiveness of interventions in reducing mortality in patients of toxic epidermal necrolysis: A network meta-analysis.
Patel TK; Patel PB; Thakkar S
Indian J Dermatol Venereol Leprol; 2021; 87(5):628-644. PubMed ID: 33871208
[TBL] [Abstract][Full Text] [Related]
24. Are steroids effective in toxic epidermal necrolysis and Stevens-Johnson syndrome?
Meza R; Rada G; Varas P
Medwave; 2017 Apr; 17(Suppl2):e6894. PubMed ID: 28430767
[TBL] [Abstract][Full Text] [Related]
25. [Reply to the article "treatment of toxic epidermal necrolysis with cyclosporine A"].
Cachafeiro L; Sánchez M; Leyva F; García de Lorenzo A
Med Intensiva; 2012; 36(5):382. PubMed ID: 22560154
[No Abstract] [Full Text] [Related]
26. Cyclosporine for Epidermal Necrolysis: Absence of Beneficial Effect in a Retrospective Cohort of 174 Patients-Exposed/Unexposed and Propensity Score-Matched Analyses.
Poizeau F; Gaudin O; Le Cleach L; Duong TA; Hua C; Hotz C; Ingen-Housz-Oro S; Sbidian E; Zehou O; Colin A; de Prost N; Lebrun-Vignes B; Chosidow O; Wolkenstein P; Fardet L
J Invest Dermatol; 2018 Jun; 138(6):1293-1300. PubMed ID: 29369774
[TBL] [Abstract][Full Text] [Related]
27. Etoricoxib-induced toxic epidermal necrolysis: successful treatment with infliximab.
Kreft B; Wohlrab J; Bramsiepe I; Eismann R; Winkler M; Marsch WC
J Dermatol; 2010 Oct; 37(10):904-6. PubMed ID: 20860742
[No Abstract] [Full Text] [Related]
28. Extensive hypertrophic scarring after toxic epidermal necrolysis in a child.
Kreft B; Lieser U; Haase R; Marsch WC; Wohlrab J
Pediatr Dermatol; 2014; 31(4):527-8. PubMed ID: 23025572
[TBL] [Abstract][Full Text] [Related]
29. Cyclosporine in Stevens Johnson syndrome and toxic epidermal necrolysis and retrospective comparison with systemic corticosteroid.
Singh GK; Chatterjee M; Verma R
Indian J Dermatol Venereol Leprol; 2013; 79(5):686-92. PubMed ID: 23974585
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporine Use in Epidermal Necrolysis Is Associated with an Important Mortality Reduction: Evidence from Three Different Approaches.
González-Herrada C; Rodríguez-Martín S; Cachafeiro L; Lerma V; González O; Lorente JA; Rodríguez-Miguel A; González-Ramos J; Roustan G; Ramírez E; Bellón T; de Abajo FJ;
J Invest Dermatol; 2017 Oct; 137(10):2092-2100. PubMed ID: 28634032
[TBL] [Abstract][Full Text] [Related]
31. [Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome].
Kühn-Córdova I; Ramírez-Bouchan D; Gamboa-Marrufo JD
An Pediatr (Barc); 2007 Jul; 67(1):68-73. PubMed ID: 17663910
[TBL] [Abstract][Full Text] [Related]
32. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study.
Schneck J; Fagot JP; Sekula P; Sassolas B; Roujeau JC; Mockenhaupt M
J Am Acad Dermatol; 2008 Jan; 58(1):33-40. PubMed ID: 17919775
[TBL] [Abstract][Full Text] [Related]
33. The use of cyclosporine for Stevens-Johnson syndrome-toxic epidermal necrolysis spectrum at the University of Louisville: A case series and literature review.
Conner CD; McKenzie E; Owen CE; Callen JP
Dermatol Online J; 2018 Jan; 24(1):. PubMed ID: 29469760
[TBL] [Abstract][Full Text] [Related]
34. Toxic epidermal necrolysis associated with severe hypocalcaemia, and treated with cyclosporin.
Zaki I; Patel S; Reed R; Dalziel KL
Br J Dermatol; 1995 Aug; 133(2):337-8. PubMed ID: 7547417
[No Abstract] [Full Text] [Related]
35. [Use of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis and Stevens-Johnson/toxic epidermal necrolysis overlap syndrome. Review of 15 cases].
Molgó M; Carreño N; Hoyos-Bachiloglu R; Andresen M; González S
Rev Med Chil; 2009 Mar; 137(3):383-9. PubMed ID: 19621180
[TBL] [Abstract][Full Text] [Related]
36. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
Ririe MR; Blaylock RC; Morris SE; Jung JY
J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
[TBL] [Abstract][Full Text] [Related]
37. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
[TBL] [Abstract][Full Text] [Related]
38. Toxic Epidermal Necrolysis in a Boy: Successful Treatment With Cyclosporine A.
Quintana-Castanedo L; Nieto-Rodríguez D; Rodríguez-Álvarez D; Feito-Rodríguez M; de Lucas-Laguna R
Actas Dermosifiliogr (Engl Ed); 2021 May; 112(5):468-470. PubMed ID: 33253652
[No Abstract] [Full Text] [Related]
39. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
[TBL] [Abstract][Full Text] [Related]
40. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
East-Innis AD; Thompson DS
West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
